Hepatitis C News

LONDON —WHO presented updated guidance on hepatitis C, calling for drastic simplification of care pathways to alleviate access gaps in HCV testing and treatment, during a joint WHO-EASL-CDC symposium at the International Liver Congress.

LONDON — Combined glecaprevir and pibrentasvir with ezetimibe prevented hepatitis C infection among patients who received non-liver solid organ transplants with HCV viremic grafts, according to research.

LONDON — Although the annual incidence of acute hepatitis C virus has decreased over the past 10 years in Frankfurt, Germany, the prevalence of HCV genotype 4 increased in men who have sex with men, according to research.

LONDON — Bulevirtide induced a greater combined virologic and biochemical response compared with control at 48 weeks in patients with chronic hepatitis D infection, according to research.

SAN DIEGO — Liver stiffness assessment predicted liver-related complications and hepatocellular carcinoma development among patients with hepatitis C following direct-acting antiviral treatment, according to research.

SAN DIEGO — A new, low-cost scoring system called TREAT-B accurately determined treatment eligibility for patients with hepatitis B virus, particularly where DNA assays are unavailable, according to research.

May 19 is Hepatitis Testing Day, and in this Healio video exclusive, Nancy S. Reau, MD, FAASLD, AGAF, stresses the importance of screening and vaccination to reach global hepatitis elimination.

There were few incident hepatitis C virus infections recorded among gay and bisexual men participating in an HIV PrEP rollout study in Australia, researchers reported.

May is Hepatitis Awareness Month, and the CDC and its public health partners are raising awareness and encouraging increased screening and vaccination.

A rapid treatment model that included a 7-day starter pack of medication significantly increased hepatitis C cure rates among young people who inject drugs, according to a small study.